Cite
Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification.
MLA
Cavaliere, Anna Franca, et al. “Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification.” International Journal of Molecular Sciences, vol. 22, no. 22, Nov. 2021, p. 12248. EBSCOhost, https://doi.org/10.3390/ijms222212248.
APA
Cavaliere, A. F., Perelli, F., Zaami, S., D’Indinosante, M., Turrini, I., Giusti, M., Gullo, G., Vizzielli, G., Mattei, A., Scambia, G., Vidiri, A., & Signore, F. (2021). Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification. International Journal of Molecular Sciences, 22(22), 12248. https://doi.org/10.3390/ijms222212248
Chicago
Cavaliere, Anna Franca, Federica Perelli, Simona Zaami, Marco D’Indinosante, Irene Turrini, Marco Giusti, Giuseppe Gullo, et al. 2021. “Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification.” International Journal of Molecular Sciences 22 (22): 12248. doi:10.3390/ijms222212248.